Sex hormone effects on body fluid regulation

Exercise and Sport Sciences Reviews

Volumn 36, Issue 3, 2008, Pages 152-159

  Stachenfeld, Nina S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

17 estradiol; Estrogens; Gonadotropin releasing hormone agonist; Gonadotropin releasing hormone antagonist; Osmoreceptors; Progesterone; Renin angiotensin aldosterone system

Indexed keywords

ARGIPRESSIN; ESTRADIOL; ESTROGEN; GANIRELIX; GONADORELIN; GONADORELIN ANTAGONIST; GONADOTROPIN; LEUPRORELIN; PROGESTERONE; SEX HORMONE; SODIUM CHLORIDE; DRUG DERIVATIVE; SODIUM;

BLOOD BRAIN BARRIER; BODY FLUID; DEHYDRATION; EXERCISE; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FLUID INTAKE; GENITAL SYSTEM; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; MENSTRUAL CYCLE; OSMOREGULATION; PLASMA OSMOLALITY; PLASMA VOLUME; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; REPRODUCTION; REVIEW; SEX DIFFERENCE; SODIUM APPETITE; SODIUM RETENTION; THIRST; TOTAL BODY WATER; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROLYTE BALANCE; FEMALE; HOMEOSTASIS; MALE; PHYSIOLOGY;

ARGININE VASOPRESSIN; BODY FLUIDS; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HOMEOSTASIS; HUMANS; LEUPROLIDE; MALE; PROGESTERONE; SALINE SOLUTION, HYPERTONIC; SODIUM; THIRST; WATER-ELECTROLYTE BALANCE;

EID: 50349096761     PISSN: 00916331     EISSN: None     Source Type: Journal    
DOI: 10.1097/JES.0b013e31817be928     Document Type: Review

References (30)

1. Almond, C.S.D., A.Y. Shin, E.B. Fortescue, R.C. Mannix, D. Wypij, B.A. Binstadt, C.N. Duncan, D.P. Olson, A.E. Salerno, J.W. Newburger, and D.S. Greenes. Hyponatremia among runners in the Boston Marathon. N. Engl. J. Med. 352:1550-1556, 2005.
2. Barron, W.M., J. Schreiber, and M.D. Lindheimer. Effect of ovarian sex steroids on osmoregulation and vasopressin secretion in the rat. Am. J. Physiol. 250(4 Pt 1):E352-E361, 1986.
3. Byers, M., G.G. Kuiper, J.A. Gustafsson, and O.K. Park-Sarge. Estrogen receptor-beta mRNA expression in rat ovary: down regulation by gonadotropins. Molecular Endocrinol. 11:172-182, 1997.
4. Calzone, W.L., C. Silva, D.L. Keefe, and N.S. Stachenfeld. Progesterone does not alter osmotic regulation of AVP. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R2011-R2020, 2001.
5. Claybaugh, J.R., A.K. Sato, L.K. Crosswhite, and L.H. Hassell. Effects of time of day, gender, and menstrual cycle phase on the human response to oral water load. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:R966-R973, 2000.
6. Dubey, R.K., and E.K. Jackson. Estrogen-induced cardiorenal protection: potential cellular, biochemical and molecular mechanisms. Am. J. Physiol. Renal. Physiol. 280:F365-F388, 2001.
7. Forsling, M.L., M. Akerlund, and P. Strömberg. Variations in plasma concentrations of vasopressin during the menstrual cycle. J. Endocrinol. 89:263-266, 1981.
8. Fraser, C.L., and A.I. Arieff. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am. J. Med. 102: 67-77, 1997.
9. Hatano, T., K. Ogawa, K. Kanda, H. Seo, and N. Masui. Effect of ovarian steroids on cyclicadenosine 3′:5′ monophosphate production stimulated by arginine vasopressin in rat renal monolayer cells. Endocrinol. Japon. 35:267-274, 1988.
10. Heritage, A.S., W.E. Stumpf, M. Sar, and L.D. Grant. Brainstem catecholamine neurons are target sites for sex steroid hormones. Science. 207:1377-1379, 1980.
11. Ishunina, T.A., F.P.M. Kruijver, R. Balesar, and D.F. Swaab. Differential expression of estrogen receptor alpha and beta immunoreactivity in the human supraoptic nucleus in relation to sex and aging. J. Clin. Endocrinol. Metab. 85:3283-3291, 2000.
12. Ishunina, T.A., and D.F. Swaab. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus; size changes in relation to sex and age. J. Clin. Endocrinol. Metab. 84:4637-4644, 1999.
13. Isles, C.G., D.J. Hole, V.M. Hawthorne, and A.F. Lever. Relation between coronary risk and coronary mortality in women of the Renfew and Paisley survey: comparison with men. Lancet. 339:702-706, 1992.
14. Kuiper, G.G., B. Carlsson, E. Enmark, J. Häggblad, S. Nilsson, and J.A. Gustafsson. Comparsion of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:863-870, 1997.
15. Kuroski de Bold, M.L. Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovasc. Res. 41:524-531, 1999.
16. Li, X., P. Schwartz, and E. Rissman. Distribution of estrogen receptor-beta-like immunoreactivity in the rat forebrain. Neuroendocrinology. 66:63-67, 1997.
17. Oberyé J.J.L., B.M.J.L. Mannaerts, J.A.M. Huisman, and C.J. Timmer. Pharmacokinetic and Pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers. Fertil. Steril. 72:1006-1012, 1999.
18. Oian, P., A. Tollan, H.O. Fadnes, H. Noddeland, and J.M. Maltau. Transcapillary fluid dynamics during the menstrual cycle. Am. J. Obstet. Gynecol. 156:952-955, 1987.
19. Orshal, J.M., and R.A. Khalil. Gender, sex hormones, and vascular tone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R233-R249, 2004.
20. Paech, K., P. Webb, G. Kuiper, S. Nilsson, J.A. Gustafsson, P.J. Kushner, and T.S. Scanlan. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1508-1510, 1997.
21. Sar, M., and W.E. Stumpf. Simultaneous localization of [3H]estradiol and neurophysin I or arginine vasopressin in hypothalamic neurons demonstrated by a combined technique of dry-mount autoradiography and immunohistochemistry. Neurosci. Lett. 17:179-184, 1980.
22. Stachenfeld, N.S., L. DiPietro, S.F. Palter, and E.R. Nadel. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am. J. Physiol. 274(1 Pt 2):R187-R195, 1998.
23. Stachenfeld, N.S., and D.L. Keefe. Estrogen effects on osmotic regulation of AVP and fluid balance. Am. J. Physiol. Endocrinol. Metab. 283:E711-E721, 2002.
24. Stachenfeld, N.S., D.L. Keefe, and S.F. Palter. Estrogen and progesterone effects on transcapillary fluid dynamics. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R1319-R1329, 2001.
25. Stachenfeld, N.S., C.S. Silva, D.L. Keefe, C.A. Kokoszka, and E.R. Nadel. Effects of oral contraceptives on body fluid regulation. J. Appl. Physiol. 87:1016-1025, 1999.
26. Stachenfeld, N.S., A.E. Splenser, W.L. Calzone, M.P. Taylor, and D.L. Keefe. Sex differences in osmotic regulation of AVP and renal sodium handling. J. Appl. Physiol. 91:1893-1901, 2001.
27. Stachenfeld, N.S., and H.S. Taylor. Progesterone increases plasma volume independent of estradiol. J. Appl. Physiol. 98:1991-1997, 2005.
28. Stachenfeld, N.S., H.S. Taylor, C.A. Leone, and D.L. Keefe. Oestrogen effects on urine concentrating response in young women. J. Physiol. 552(Pt 3):869-880, 2003.
29. Stachenfeld, N.S., and H.S. Taylor. Effects of estrogen and progesterone administration on extracellular fluid. J. Appl. Physiol. 96:1011-1018, 2004.
30. Tollan, A., K. Kvenild, H. Strand, P. Oian, and J.M. Maltau. Increased capillary permeability for plasma proteins in oral contraceptive users. Contraception. 45:473-481, 1992.